Showing 1 - 15 results of 15 for search 'S. H. Ramkissoon', query time: 0.06s
Refine Results
-
1
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associa... by Zachary D. Wallen, Mary K. Nesline, Marni Tierno, Alison Roos, Erica Schnettler, Hatim Husain, Pratheesh Sathyan, Brian Caveney, Marcia Eisenberg, Eric A. Severson, Shakti H. Ramkissoon, Shakti H. Ramkissoon
Published 2024-11-01
Article -
2
-
3
Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression by Brennan Decker, Richard S.P. Huang, Karthikeyan Murugesan, Douglas A. Mata, Jeffrey S. Ross, Matthew Hiemenz, Gerald Li, James Creeden, Shakti H. Ramkissoon
Published 2021-06-01
Article -
4
Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency by Prashanth Ashok Kumar, Stephen L. Graziano, Natalie Danziger, Dean Pavlick, Eric A. Severson, Shakti H. Ramkissoon, Richard S. P. Huang, Brennan Decker, Jeffrey S. Ross
Published 2023-01-01
Article -
5
Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer by Zachary D. Wallen, Heidi Ko, Mary K. Nesline, Stephanie B. Hastings, Kyle C. Strickland, Kyle C. Strickland, Rebecca A. Previs, Rebecca A. Previs, Shengle Zhang, Sarabjot Pabla, Jeffrey Conroy, Jennifer B. Jackson, Kamal S. Saini, Taylor J. Jensen, Marcia Eisenberg, Brian Caveney, Pratheesh Sathyan, Eric A. Severson, Shakti H. Ramkissoon, Shakti H. Ramkissoon
Published 2024-06-01
Article -
6
Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors by A. Giannoudis, E. S. Sokol, T. Bhogal, S. H. Ramkissoon, E. D. Razis, R. Bartsch, J. A. Shaw, K. McGregor, Alison Clark, R.S.P. Huang, C. Palmieri
Published 2024-12-01
Article -
7
Atypical presentation of cerebral schistosomiasis four years after exposure to Schistosoma mansoni by Matthew F. Rose, Eli E. Zimmerman, Liangge Hsu, Alexandra J. Golby, Emam Saleh, Rebecca D. Folkerth, Sandro S. Santagata, Danny A. Milner Jr., Shakti H. Ramkissoon
Published 2014-01-01
Article -
8
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors by Lori A. Ramkissoon, Worthy Pegram, James Haberberger, Natalie Danziger, Glenn Lesser, Roy Strowd, Sonika Dahiya, Thomas J. Cummings, Wenya Linda Bi, Malak Abedalthagafi, Pratheesh Sathyan, Kimberly McGregor, Prasanth Reddy, Eric Severson, Erik Williams, Douglas Lin, Claire Edgerly, Richard S. P. Huang, Amanda Hemmerich, James Creeden, Charlotte Brown, Jeffrey Venstrom, Priti Hegde, Jeffrey S. Ross, Brian M. Alexander, Julia Elvin, Shakti H. Ramkissoon, Shakti H. Ramkissoon
Published 2020-10-01
Article -
9
Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin by Douglas I. Lin, Nikunj Shah, Julie Y. Tse, Jonathan K. Killian, Amanda Hemmerich, Claire Edgerly, James Haberberger, Eric A. Severson, Richard S.P. Huang, Shakti H. Ramkissoon, Jo-Anne Vergilio, Jeffrey S. Ross, Julia A. Elvin
Published 2020-11-01
Article -
10
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic by Erik A. Williams, Sandro Santagata, Hiroaki Wakimoto, Ganesh M. Shankar, Fred G. Barker, Radwa Sharaf, Abhinav Reddy, Phoebe Spear, Brian M. Alexander, Jeffrey S. Ross, Priscilla K. Brastianos, Daniel P. Cahill, Shakti H. Ramkissoon, Tareq A. Juratli
Published 2020-10-01
Article -
11
Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia. by Nahla A Mobark, Musa Alharbi, Lamees Alhabeeb, Latifa AlMubarak, Rasha Alaljelaify, Mariam AlSaeed, Amal Almutairi, Fatmah Alqubaishi, Maqsood Ahmad, Ayman Al-Banyan, Fahad E Alotabi, Duna Barakeh, Malak AlZahrani, Hisham Al-Khalidi, Abdulrazag Ajlan, Lori A Ramkissoon, Shakti H Ramkissoon, Malak Abedalthagafi
Published 2020-01-01
Article -
12
Correlating ROS1 Protein Expression With ROS1 Fusions, Amplifications, and Mutations by Richard S.P. Huang, MD, Amanda Gottberg-Williams, BS, Panhia Vang, BS, Shoua Yang, HSD, Nicholas Britt, BS, Jaspreet Kaur, MS, James Haberberger, BS, Natalie Danziger, BS, Clarence Owens, BS, Sara E. Beckloff, PhD, Jeffrey S. Ross, MD, Shakti H. Ramkissoon, MD, PhD
Published 2021-02-01
Article -
13
Molecular and clinicopathologic features of gliomas harboring NTRK fusions by Matthew Torre, Varshini Vasudevaraja, Jonathan Serrano, Michael DeLorenzo, Seth Malinowski, Anne-Florence Blandin, Melanie Pages, Azra H. Ligon, Fei Dong, David M. Meredith, MacLean P. Nasrallah, Craig Horbinski, Sonika Dahiya, Keith L. Ligon, Mariarita Santi, Shakti H. Ramkissoon, Mariella G. Filbin, Matija Snuderl, Sanda Alexandrescu
Published 2020-07-01
Article -
14
Cancer Trials Ecosystem in India—Ready for Prime Time? by Arun K. Mankan, Abhishek Shankar, Sewanti Limaye, B.S. Ajaikumar, Prajakta Nachane, Navneet Singh, Shekhar Dawkhar, Ullas Batra, Amol Bhosekar, Sandip Ganguly, Pramod Gawli, Khokan Debnath, Vivek Padalalu, Prasanth Reddy, Shanthi Sundaramoorthy, K.K. Naveen, Shailesh Bondarde, Praveen Kumar, Sanish Davis, Shakti H. Ramkissoon, Raju Titus Chacko, Laura Vidal, Isagani Chico, Andrew Hegedus, Sudeep Gupta, Kamal S. Saini
Published 2024-06-01
Article -
15
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors by Jonathan W. Riess, Shaila Rahman, Waleed Kian, Claire Edgerly, Andreas M. Heilmann, Russell Madison, Shakti H. Ramkissoon, Shai Shlomi Klaitman, Jon H. Chung, Sally E. Trabucco, Dexter X. Jin, Brian M. Alexander, Samuel J. Klempner, Lee A. Albacker, Garrett M. Frampton, Laila C. Roisman, Vincent A. Miller, Jeffrey S. Ross, Alexa B. Schrock, Jeffrey P. Gregg, Nir Peled, Ethan S. Sokol, Siraj M. Ali
Published 2021-10-01
Article